Fyn kinase activity is required for normal organization and functional polarity of the mouse oocyte cortex.
The objective of the present study was to determine whether Fyn kinase participated in signaling events during sperm-egg interactions, sperm incorporation, and meiosis II. The functional requirement of Fyn kinase activity in these events was tested through the use of the protein kinase inhibitor SKI-606 (Bosutinib) and by analysis of Fyn-null oocytes. Suppression of Fyn kinase signaling prior to fertilization caused disruption of the functional polarity of the oocyte with the result that sperm were able to fuse with the oocyte in the immediate vicinity of the meiotic spindle, a region that normally does not allow sperm fusion. The loss of functional polarity was accompanied by disruption of the microvilli and cortical granule-free zone that normally overlie the meiotic spindle. Changes in the distribution of cortical granules and filamentous actin provided further evidence of disorganization of the oocyte cortex. Rho B, a molecular marker for oocyte polarity, was unaffected by suppression of Fyn activity; however, the polarized association of Par-3 with the cortex overlying the meiotic spindle was completely disrupted. The defects in oocyte polarity in Fyn-null oocytes correlated with a failure of the MII chromosomes to maintain a position close to the oocyte cortex which seemed to underlie the above defects in oocyte polarity. This was associated with a delay in completion of meiosis II. Pronuclei, however, eventually formed and subsequent mitotic cleavages and blastocyst formation occurred normally.
Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Jinping
J
Luo
Lynda K
LK
McGinnis
William H
WH
Kinsey
D008841:Actin Cytoskeleton / Q000378:metabolism; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D016764:Cell Polarity; D002875:Chromosomes / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D008297:Male; D008540:Meiosis; D051379:Mice; D008871:Microvilli / Q000378:metabolism; D009570:Nitriles / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology / Q000201:enzymology* / Q000502:physiology; D051076:Proto-Oncogene Proteins c-fyn / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011804:Quinolines / Q000494:pharmacology; D018075:RNA, Complementary / Q000235:genetics; D015398:Signal Transduction; D013084:Sperm-Ovum Interactions; D019061:src-Family Kinases / Q000235:genetics / Q000378:metabolism
D000814:Aniline Compounds; D009570:Nitriles; D011804:Quinolines; D018075:RNA, Complementary; C471992:bosutinib; C494960:Fyn protein, mouse; D051076:Proto-Oncogene Proteins c-fyn; D019061:src-Family Kinases